Genetic Registry for Rheumatoid Arthritis (NARAC)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00069472|
Recruitment Status : Completed
First Posted : September 29, 2003
Last Update Posted : September 10, 2015
|Condition or disease|
The identification of genes for complex disorders such as RA requires large numbers of genetically informative families. This study enrolls people diagnosed with with RA and their families.
This study will enroll 1000 RA patients and their parents. Participants with RA will be evaluated at his or her doctor's office or other location convenient for the participant. Participants will have a brief phone interview with a study coordinator and a blood sample will be obtained. Disease evaluation will be done at one visit and will include confirmation of diagnosis, a 28 joint count, joint alignment and mobility score (JAMS) and administration of a health assessment questionnaire.
|Study Type :||Observational|
|Actual Enrollment :||1062 participants|
|Official Title:||Genetics of Rheumatoid Arthritis Registry|
|Study Start Date :||October 2002|
|Actual Primary Completion Date :||August 2015|
|Actual Study Completion Date :||August 2015|
- Genetic Association with risk for rheumatoid arthritis [ Time Frame: 10 years ]The project aims to identify risk alleles for rheumatoid arthritis using association methods in trio families, combined with data from singleton cases and multiplex families
Biospecimen Retention: Samples With DNA
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00069472
|United States, New York|
|Feinstein Institute for Medical Research|
|Manhasset, New York, United States, 11030|
|Principal Investigator:||Peter K. Gregersen, MD||North Shore University Hospital|